Innovision IPO GMP: Key Details and Subscription Status

Innovision IPO Opens for Subscription

Innovision Ltd’s initial public offering (IPO) opened for public subscription on March 10, 2026, and is set to close on March 12, 2026. The company, based in Gurgaon and specializing in integrated facility management, aims to raise ₹322.84 crore through this offering. The price band for the IPO is set between ₹521 and ₹548 per share, with a minimum lot size of 27 shares.

Current Subscription Status

As of March 11, 2026, the Innovision IPO has been subscribed 12%. Within this figure, the Retail Individual Investors (RIIs) category has seen a subscription rate of 6%, while Qualified Institutional Buyers (QIBs) have shown significant interest, achieving a subscription rate of 96%. This strong demand from institutional investors indicates a positive outlook for the IPO.

GMP and Expected Listing Price

Today’s Grey Market Premium (GMP) for the Innovision IPO stands at ₹71 per share. This suggests that the estimated listing price of the stock could be around ₹619 apiece, reflecting a potential gain for investors who participate in the offering. The GMP is a crucial indicator for market participants, often used to gauge the expected performance of the stock post-listing.

Key Dates to Note

The allotment date for the Innovision IPO is scheduled for March 13, 2026, while the listing date on the stock exchange is anticipated to be March 17, 2026. These dates are critical for investors as they mark the transition from subscription to trading on the market.

Innovision Ltd has positioned itself as a key player in the facility management sector, catering to a diverse range of clients. The company’s strategic initiatives and operational efficiencies have contributed to its growth, making the IPO a significant milestone in its corporate journey.

Market Expectations

Observers are closely monitoring the subscription trends and GMP as the IPO progresses. The strong interest from QIBs, in particular, may bolster confidence among retail investors. However, details remain unconfirmed regarding the final subscription figures as the closing date approaches.

As the Innovision IPO continues to attract attention, stakeholders are keenly awaiting the final subscription numbers and the subsequent market performance. The combination of a robust GMP and high institutional interest sets the stage for a potentially successful listing.